The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency

European Journal of Endocrinology

Volumn 142, Issue 3, 2000, Pages 254-162

  Evans, L M ^a   Davies, J S ^a   Anderson, R A ^a   Ellis, G R ^a   Jackson, S K ^a   Lewis, M J ^a   Frenneaux, M P ^a   Rees, A ^a   Scanlon, M F ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FREE RADICAL; GROWTH HORMONE; HYDROCORTISONE; TESTOSTERONE; THYROXINE;

ADENOHYPOPHYSIS HYPOFUNCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; METABOLIC PARAMETERS; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034067830     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420254     Document Type: Article

References (46)

1. Rosen T & Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. The Lancet 1990 336 285-288.
2. Bates AS, Hoff WV, Jones PJ & Clayton RN. The effects of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism 1996 81 1169-1172.
3. Binnerts A, Duerenberg P, Swart GR, Wilson JHP & Lamberts SWJ. Body composition in growth hormone deficient adults. American Journal of Clinical Nutrition 1992 55 918-923.
4. Cuneo RC, Salomon F, Wiles CM, Hesp R & Sonksen PH. Growth hormone treatment in growth hormone deficient adults. I. Effects on muscle mass and strength. II. Effects on exercise performance. Journal of Applied Physiology 1991 70 688-694 & 695-700.
5. Johansson JO, Fowelin J, Landin K, Lager I & Bengtsson BA. Growth hormone deficient adults are insulin resistant. Metabolism 1995 44 434-437.
6. Russell-Jones DL, Watts GF, Weissberger A, Naoumova R, Myers J, Thompson GR et al. The effect of GH replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult GHD patients. Clinical Endocrinology 1994 41 345-350.
7. O'Neal D, Few FL, Sikaris K, Ward G, Alford F & Best JD. Low-density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. Journal of Clinical Endocrinology and Metabolism 1996 81 2448-2454.
8. Al-Shoumer KAS, Cox KH, Hughes CL, Richmond W & Johnston DG. Fasting and post-prandial lipid abnormalities in hypopituitary women receiving conventional hormone replacement therapy. Journal of Clinical Endocrinology and Metabolism 1997 82 2653-2659.
9. Carrol V, Christ ER, Bengtsson BA, Christiansen JS, Clemmons D, Hintz R et al. GH deficiency in adulthood and the effect of GH replacement. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
10. Wenmalm A. Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolaemia. Blood Pressure 1994 5 279-282.
11. Jessup W. Oxidised lipoproteins and nitric oxide. Current Opinion in Lipidology 1996 7 274-280.
12. Henderson A. Endothelium in control. British Heart Journal 1991 65 116-125.
13. Celermajer D, Sorenson K, Gooch V, Spiegelhalter D & Deanfield J. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet 1992 340 1111-1115.
14. Kerr ME, Boundr LM & Monti EJ. An introduction to oxygen free radicals. Heart and Lung 1996 25 200-209.
15. Yagi K. Lipid peroxides and human diseases. Chemistry Physiology Lipids 1987 45 337-342.
16. Cannon RO. Role of nitric oxide in cardiovascular disease. Clinical Chemistry 1998 44 1809-1819.
17. Kostner K, Hornykewycz S, Yang P, Neuntful T, Eeidinger F, Mourer G et al. Is oxidative stress causally linked to unstable angina pectoris? A study of 100 CAD patients and matched controls. Cardiovascular Research 1997 36 330-336.
18. Ferrari R, Arolletti L, Commini L, Gavia G, Cargnomi A, Curello S et al. Oxidative stress during myocardial ischaemia and heart failure. European Heart Journal 1998 19 Suppl B B2-B11.
19. Ramsey M, Goodfellow J, Jones C, Luddington L, Lewis M & Henderson A. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995 92 3212-3219.
20. Ashton T, Rowlands CC, Jones E, Young IS, Jackson SK, Davies B et al. Electron spin resonance spectroscopic detection of oxygen-centred radicals in human serum following exhaustive exercise. European Journal of Applied Physiology 1998 77 498-502.
21. Tortolani AJ, Powell SR, Misik V, Weglicki WB, Pogo GJ & Kramer JH. Detection of alkoxyl and carbon-centred radicals in coronary sinus blood from patients undergoing elective cardioplegia. Free Radicals Biology and Medicine 1993 14 421-426.
22. Grech ED, Dodd NJF, Jackson MJ, Morrison WL, Faragher EB & Ramsdale DR. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. American Journal of Cardiology 1996 77 122-127.
23. Allain CC, Poon LS, Chan CSG, Richmond W & Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry 1974 20 470-475.
24. Wahlefeld AW. Triglycerides. Determination after enzymatic hydrolysis. In Methods of Enzymatic Analysis, pp 1851-1835. Ed. HU Bergmeyer. New York: Verlag Chemie Weinheim, Academic Press Inc., 1974.
25. Warnick GR, Nguyen T & Albers AA. Comparison of improved precipitation methods for quantification of HDL cholesterol. Clinical Chemistry 1985 31 217-222.
26. Friedewald WT, Levy RL & Fredrickson DS. Estimation of the concentration of LDL cholesterol without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
27. Bang P, Eriksson U, Sara V, Wivall IL & Hall K. Comparison of acid ethanol extraction and acid gel liltration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinology 1991 124 620-629.
28. Berkenboom G, Gresset V, Giot C, Unger P, Vachiery JI, & LeClerc JL. Endothelial function of internal mammary artery in patients with coronary artery disease and in cardiac transplant patients. American Heart Journal 1998 135 488-494.
29. de Boer H & van der Veen H. Guidelines for optimizing growth hormone replacement therapy in adults. Hormone Research 1997 48 Suppl 5 21-30.
30. Voors AA, Oosterga M, Buehema H, May JF, Grandjean JG, Van-buten A et al. Dyslipidaemia and endothelium dependent function in internal mammary arteries used for coronary bypass surgery. Cardiovascular Research 1997 34 568-574.
31. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC & Krauss RM. Low density lipoprotein subclass patterns and the risk of myocardial infarction. Journal of the American Medical Association 1988 260 1917-1921.
32. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witztum JL. Beyond cholesterol: modifications of LDL that increase its atherogenicity. New England Journal of Medicine 1989 320 915-924.
33. Galle J. Impairment of endothelium-dependent dilatation in rabbit renal arteries by oxidised LDL. Circulation 1995 92 1582-1589.
34. Harrison DG & Ohara Y. Physiologic consequences of increased vascular oxidant stress in hypercholesterolaemia; implications of impaired vasomotion. American Journal of Cardiology 1995 75 75B-81B.
35. Paronini P, Angelin B, Lobie PE, Norstedt G, & Rudling M. Growth hormone specifically stimulates the expression of LDL receptors in human hepatoma cells. Endocrinology 1995 136 3767-3773.
36. Lynch SM, Frei B, Morrow JD, Roberts LJ 2nd, Xu A, Reyna R et al. Vascular superoxide dismutase deficiency impairs vasodilator function through direct inactivalion of nitric oxide and increased lipid peroxidation. Arteriosclerosis, Thrombosis and Vascular Biology 1997 11 2975-2981.
37. Jacob AK, Hotchkiss RS, DeMeester SL, Hiramatsu M, Karl IE, Swanson PE et al. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery 1997 122 243-253.
38. Steinbrecher P, Zhang HF & Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radicals Biology and Medicine 1990 9 155-168.
39. Harrison DG. Endothelial function and oxidant stress. Clinical Cardiology 1997 20 Suppl 2 II-11-7.
40. Tsukahara H, Gordienko DV, Tonshof B, Gelato MC & Goligorskv MS. Direct demonstration of insulin like growth faclor-1-induced nitric oxide production by endothelial cells. Kidney International 1994 45 598-604.
41. Boger RH, Skamira C, Bode-Buger SM, Brabant G, von zur Muhlen A & Frolich JC. Nitric oxide may mediate the haemodynamic effects of recombinant human GH in patients with acquired GHD. Journal of Clinical Investigation 1996 98 2706-2713.
42. Despres JP. Dyslipidaemia and obesity Balliere's Clinical Endocrinology and Metabolism 1994 8 629-653.
43. Saltar N, Petrie JP & Jaap JA. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis 1998 138 229-235.
44. Foure P, Rossini E, Lafond JL, Richard MJ, Favier A & Halimi S. Vitamin E improves the free radical defence system potential and insulin sensitivity of rats led high fructose diets. Journal of Nutrition 1997 127 103-107.
45. Bones C, Bellamy M, Brownlee M, Goodfellow J, Ramsey MW, Lewis MJ et al. Endothelial function in healthy young adults is rapidly improved by physical training. European Heart Journal 1997 18 265.
46. Nieubauer J & Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. Journal of the American College of Cardiology 1996 28 1652-1660.